Adial Pharmaceuticals Stock Overlap Studies Double Exponential Moving Average

ADIL Stock  USD 1.01  0.01  0.98%   
Adial Pharmaceuticals overlap studies tool provides the execution environment for running the Double Exponential Moving Average study and other technical functions against Adial Pharmaceuticals. Adial Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Double Exponential Moving Average study function is designed to identify and follow existing trends. Adial Pharmaceuticals overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was four with a total number of output elements of fifty-seven. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to Adial Pharmaceuticals changes than the simple moving average.

Adial Pharmaceuticals Technical Analysis Modules

Most technical analysis of Adial Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Adial from various momentum indicators to cycle indicators. When you analyze Adial charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Adial Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Adial Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adial Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Adial Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adial Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Adial Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Adial Pharmaceuticals, we also check how macroeconomic factors affect Adial Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Hype
Prediction
LowEstimatedHigh
0.051.014.89
Details
Intrinsic
Valuation
LowRealHigh
0.915.859.73
Details
Naive
Forecast
LowNextHigh
0.021.034.91
Details
3 Analysts
Consensus
LowTargetHigh
18.6620.5022.76
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adial Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adial Pharmaceuticals' short interest history, or implied volatility extrapolated from Adial Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Video Games Idea
Video Games
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Business Services Idea
Business Services
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
When determining whether Adial Pharmaceuticals is a strong investment it is important to analyze Adial Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adial Pharmaceuticals' future performance. For an informed investment choice regarding Adial Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.94)
Return On Assets
(1.04)
Return On Equity
(3.21)
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.